Guidance
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Common Specifications: An Antidote To MDR’s Clinical Evidence ‘Moveable Feast’?
Unpredictable clinical evidence expectations under the new EU medtech regulations can have a chilling effect on even the most established companies, resulting in product withdrawals. Medtech Insight asked a regulatory expert how this crisis can be avoided.
Real Or Fake? FDA Seeks To Clarify The Definitions Of Legitimate Medical Devices And Counterfeit Ones
The 2020 Safeguarding Therapeutics Act added the term “counterfeit devices” to the US FDA’s lexicon, giving the agency the authority to keep them out of the country or even destroy them.
Combination Product Human Factors Final Guidance In Clearance, OCP Says
The OCP presented its priorities for 2023 and beyond at the RAPS/AFDO Combination Products Summit on 8 November.
Global Medtech Guidance Tracker: October 2022
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-six documents have been posted on the tracker since its last update.
FDA Updates 'Least Burdensome' Guidance To Match MDUFA V
An updated final guidance document from the US Food and Drug Administration lays out how regulators should structure deficiency letters when asking sponsors for additional information.
Australia Proposes New Guidance On Regulating Boundary & Combination Products
The Australian regulator wants to hear stakeholders’ views on proposals to help decide whether a product is a medicine, a medical device or a biological – or none of the above.
FDA Takes Aim At Reducing Health Disparities Through Breakthrough Devices Program
Proposed updates to the US FDA’s breakthrough devices program guidance would help to clarify how the program may be applicable to devices that treat and diagnose diseases that disproportionately affect certain populations.
Guidance On Regulating AI As A Medical Device Not Top 2023 Priority For FDA
The US FDA’s Center for Devices and Radiological Health has posted the guidance documents it plans to focus on in fiscal year 2023, and guidance on regulating AI as a medical device is not first up.
‘Project Glass Box’ - UK Reveals Roadmap For AI Medtech Regulation
The MHRA recently announced plans to review and reform how medical devices with AI or software components are to be regulated in the UK. Its new roadmap sheds light on how, exactly, it will deliver on these ambitions.
LASIK Comments Show Divided Opinions As FDA Extends Feedback Period
The comment period for a draft guidance document on labeling for LASIK surgery equipment has been extended for another month. Ninety people have already filed comments, representing a wide range of views about the procedure.
Final Guidance Docs Outline Best Practices For FDA Postmarket Studies
The agency advises device makers on its recommendations for postmarket surveillance, both when required under a PMA and when conducted under a 522 order.
Expert: New Guidance May Demand Clinical Decision Support Software Re-Evaluation
Businesses should reevaluate the classification of their clinical decision software based on a new FDA guidance, Kyle Faget of Foley & Lardner LLP tells Medtech Insight.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.